ABSTRACT
Chitosan oligosaccharide(COS)is the N-acetyl-D-glucosamine and D-glucosamine oligomer linked to β(1→4)glycoside bond, which is an amino oligosaccharide with positive charge. GOS can be prepared via the deacetylation and hydrolysis of chitin from the exoskeleton of arthropod and insect and the cell wall of fungi. GOS is soluble in water, not cytotoxic, easy to be absorbed through intestinal tract, and mainly excreted from urine. COS and its derivatives have been known to have a variety of biological activities, including the anti-inflammatory, immunomodulatory, neuroprotective and antioxidant activities. This paper reviews the research progress in the preparation method, pharmacokinetics, bioactivity and the safety of GOS in recent years, hoping to provide a reference for related future researches.
ABSTRACT
Objective:To prepare PLGA nanoparticles modified with folic acid conjugated chitosan oligosaccharide containing pa-clitaxel (F-CS-PLGA-NPs) and study the inhibitory effect on SKOV-3. Methods:F-CS-PLGA-NPs were prepared by an interface dep-osition method, 30% ethanol was used as the release medium for the in vitro release profiles of nanoparticles, and MTT was adopted to evaluate the inhibitory effect of paclitaxel with different formulations and concentrations on SKOV-3. Results:The particle size and zeta potential of F-CS-PLGA-NPs was (321 ± 0. 76) nm and (22. 6 ± 0. 26) mV, respectively, the drug loading was (5. 1 ± 0. 25)%, and the encapsulation efficiency was (41. 96 ± 1. 96)%. F-CS-PLGA-NPs had a similar in vitro release profiles with the ordinary nanoparti-cles ( PLGA-NPs) . About 35% of paclitaxel was released from the nanoparticles in the initial 24 h, and then a near zero order release at a relative slow rate was shown, and the cumulative release rate in 144 h was about 75%. The results of cell experiments suggested that at the same paclitaxel concentration, the inhibition effect of F-CS-PLGA-NPs group was stronger than that of the PLGA-NPs group and the solution group. The inhibition effect of F-CS-PLGA-NPs could be reduced by free folic acid. Conclusion:PLGA nanoparticles modified with folic acid conjugated chitosan oligosaccharide can increase the targeting efficiency in SKOVS-3 tumor cells.
ABSTRACT
Objective: To investigate the therapeutic effect of oat β-glucans on serum lipid levels of rats with experimental hyperlipemia. Methods: Rats were fed on high fat forage for 3 weeks to establish hyperlipemia models, then the model rats were orally given oat β-glucans at doses of 133, 266 and 533 mg/(kg · d) separately. At the same time, there were 3 control groups including chitosan ligosaccharide[200 mg/(kg · d)], normal, and high blood lipid (model rats fed with distilled water). Serum levels of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) were assayed in rats of all groups and the results were compared. Results: β-glucans obviously decreased the levels of TC and LDL-C and increased HDL-C in rat hyperlipemia models. The reduction of serum lipid level in 4-week β-glucans treatment rats was more obvious than that in 3-week β-glucans treatment rats. Besides, β-glucans showed an obvious dosage dependent effect in reducing serum lipid level without adverse effect. Oat β-glucans had a better lipid-reducing effect than ligosaccharide did. Conclusion: Oat β-glucans can obviously decrease serum lipid in rats with hyperlipemia.
ABSTRACT
Objective Experiment the tumor animal model of the H22 Cancer of the liver mile,study the inhibition effect of chitosan oligosaccharide and bifidobacteria on tumour.Methods the growth of tumour were observed after chitosan oligosaccharide and bifidobacteria were injected into tumor-bearing mice;then the immunify funcfion weremcasured.Results Growth of tumour were inhibited by chitosan oligosaccharide and bifidobacteria,they can increase the content of IL-2 and IFN-?and the weight of spleen and thymus of the mice.Conclusions chitosan oligosaccharide and bifidobacteria could inhibit the growth of tumour,inproue immunity function.
ABSTRACT
To determine the number average molecular mass of chitosan-oligosaccharide by u-sing the acetylacetone's method based on the color-producing reaction with amino terminal . Via the tests on the repetitiveness, accuracy and the stability, supposed this method was reliable. At the same time, the contrastive results of HPLC and the traditional K3Fe(CN)6 method indicate that the acetylacetone method was more suitable for the determination of chitosan-oligosaccharide molecular mass.
ABSTRACT
Objective: To investigate the inhibitory effects of chitosan oligosaccharide on tumor growth in vivo. Methods: Murine tumor cell line H22 was inoculated into. Then different doses of chitosan oligosaccharide were injected into the mice-bearing H22 liver carcinoma, IL-2 and IFN-? in the sera were measured by ELISA assay. The in vitro anti-proliferation activity of chitosan oligosaccharide on the lung carcinoma LH-7 cells was evaluated by MTT assay. Results: Chitosan oligosaccharide inhibited in vivo the growth of H22 tumor cells,with increasing the content of IL-2 and IFN-? in sera of the tumor-bearing mice. The weight of spleen and thymus of the mice were increased when compared with those of control group; tissue necrosis was observed in the tumor in situ; chitosan oligosaccharide also inhibited the growth of LH-7 cells in vitro. The inhibitory effect was shown in a concentration dependent pattern, but not correrlated with incubation time. The early characteristics of apoptosis of LH-7 cell could be observed under the transmission electronic microscopy. Conclusion: Chitosan oligosaccharide inhibits proliferation of tumor and improves immunity function of the hosts, and might induce apoptosis of LH-7 cells.
ABSTRACT
Objective:To investigate the therapeutic effect of oat ?-glucans on serum lipid levels of rats with experimental hyperlipemia.Methods: Rats were fed on high fat forage for 3 weeks to establish hyperlipemia models,then the model rats were orally given oat ?-glucans at doses of 133,266 and 533 mg/(kg?d) separately.At the same time,there were 3 control groups including chitosan ligosaccharide[200 mg/(kg?d)],normal,and high blood lipid(model rats fed with distilled water).Serum levels of total cholesterol(TC),high density lipoprotein cholesterol(HDL-C) and low density lipoprotein cholesterol(LDL-C) were assayed in rats of all groups and the results were compared.Results: ?-glucans obviously decreased the levels of TC and LDL-C and increased HDL-C in rat hyperlipemia models.The reduction of serum lipid level in 4-week ?-glucans treatment rats was more obvious than that in 3-week ?-glucans treatment rats.Besides,?-glucans showed an obvious dosage dependent effect in reducing serum lipid level without adverse effect.Oat ?-glucans had a better lipid-reducing effect than ligosaccharide did.Conclusion: Oat ?-glucans can obviously decrease serum lipid in rats with hyperlipemia.
ABSTRACT
Objective To investigate the therapeutic effect of oat ?-glucans on liver injury in hyperlipemia rats.Method Rats were fed on high fat forage for 3 w to establish hepatic injury model,then the model group was orally given oat ?-glucans at doses of 133,266 and 533 mg/(kg bw.d) respectively.At the same time,there were 3 control groups including 200 mg/(kg bw.d) chitosan oligosaccharide,normal and liver injury(model group fed with distilled water).Serum levels of ALT and AST,the content of MDA in serum and liver homogenate was assayed.Results Oat ?-glucans at high dose obviously decreased the levels of ALT,AST and MDA in the liver injury models,SP had a better protective effect on the liver injury than oligosaccharide did.Besides,in the treated group with ?-glucans,degenerative and necrotic changes of the liver cells were apparently milder than those of the untreated group.Conclusion Oat ?-glucans can obviously relieve the liver injury in hyperlipemia rats.